clinicaltrialvanguard

EC Approves Obicetrapib as Oral CETP Inhibitor for Hypercholesterolemia

European Commission approves obicetrapib, a CETP inhibitor for hypercholesterolemia, offering oral dosing and 41% LDL-C reduction in Phase 3 trials.

Taking 32p pill proven to reduce high cholesterol and it's available at Boots

Boots is selling a 32p pill that has been shown to reduce high cholesterol and help maintain healthy levels. According to the ...

A single pill could slash your risk of stroke and heart attack—here’s how

Cholesterol: A Hidden Threat That’s Hard to Tame In France, more than one in five adults lives with high cholesterol, ...

Teva Highlights New Real-World Data Showing UZEDY® (risperidone) Outperforms Other Long-Acting Injectables in Keeping Schizophrenia Patients on Treatment, Whi…

New findings show favorable treatment continuity for UZEDY compared to other long-acting injectables in schizophrenia, as ...

Teva Highlights New Real-World Data Showing UZEDY® (risperidone) Outperforms Other Long-Acting Injectables in Keeping Schizophrenia Patients on Treatment, While Reducing ...

New findings show favorable treatment continuity for UZEDY compared to other long-acting injectables in schizophrenia, as well as oral ...
YouTube on MSNOpinion

I tried statins - and stopped. Here's why I'm concerned.

When I tried statin therapy as part of an experiment, I quickly developed a common side effect. But what concerned me wasn’t ...